glp-1 zepbound Major insurance changes are coming to drugs for weight loss. Here's how that could affect patients Study flags need to monitor

Glucagon-like peptide-1 receptor agonist (GLP-1RA), a novel hypoglycemic agent for the treatment of type 2 diabetes, has well-known effects such as lowering ...

Explore The Impact of GLP-1 on the Food Industry and how it reshapes consumer eating habits and food innovation.

The prescribing of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has surged for the treatment of diabetes and obesity, with more than 15 million users worldwide

Have you noticed changes in your mood or personality since starting a glucagon-like peptide-1 (GLP-1) receptor agonist

Review your health history, discuss medication and lifestyle options, and build a plan with your provider.

The FDA recently approved versions of GLP-1 medication - including Wegovy (semaglutide), Saxenda (liraglutide), and Zepbound (tirzepatide) - for chronic weight management